MedChemComm · 2018 · 26 citations · 25 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsCytotoxic ChemotherapyOncology PharmacologyStructure-activity Relationship AnalysisTopoisomerase InhibitorsAntiproliferative AgentsBenzimidazole ChemistryCatalytic Topoisomerase InhibitionCleavageDna Topoisomerase Ii InhibitionElectronic Structure EffectsTopoisomerase Ii FunctionTopoisomerase Ii Inhibitors
In this study, a series of benzimidazole-rhodanine conjugates were designed, synthesized and investigated for their topoisomerase II (Topo II) inhibitory and cytotoxic activities. The results from Topo II-mediated pBR322 DNA relaxation and cleavage assays showed that the synthesized compounds might act as Topo II catalytic inhibitors. Certain compounds displayed potent Topo II inhibition at 10 μM. The cytotoxic activities of these compounds against HeLa, A549, Raji, PC-3, MDA-MB-201, and HL-60 cancer cell lines were evaluated. The results indicated that these compounds exhibited strong antiproliferative activity. A good relationship was observed between the Topo II inhibitory potency and the cytotoxicity of these compounds. The structure-activity relationship revealed that the electronic effects, the phenyl group, and the rhodanine moiety were particularly important for the Topo II inhibitory potency and cytotoxicity.
25
Ashish T. Baviskar, Chetna Madaan, Ranjan Preet et al. · Journal of Medicinal Chemistry · 2011 · 292 citations · Full text